Skin-derived fibroblasts for treatment of Achilles tendinosis – ARTICLE RETRACTED .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Skin-derived fibroblasts for the treatment of refractory Achilles tendinosis: preliminary short-term results
J Bone Joint Surg Am. 2012 Feb 1;94(3):193-20032 patients (40 Achilles tendons), suffering from persistent Achilles tendinosis, were randomized to assess the safety and efficacy of autologous skin-derived fibroblast injection. Patients either received an injection with autologous fibroblasts or with an anesthetic. Patients receiving an anesthetic injection also received physiotherapy. Blinded outcome assessment indicated that VISA and VAS pain scores were significantly reduced in the autologous fibroblast group, but not in the control group at 6 month follow-up. The Journal of Bone and Joint Surgery released a letter expressing concern of potential unethical behavior with regard to the research published in this article. Readers should be aware of these concerns and interpret this research with extreme caution.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
